| Estimating the budget impact of orphan medicines in Europe: 2010-2020 C Schey, T Milanova, A Hutchings Orphanet journal of rare diseases 6, 1-10, 2011 | 175 | 2011 |
| Estimating the budget impact of orphan drugs in Sweden and France 2013–2020 A Hutchings, C Schey, R Dutton, F Achana, K Antonov Orphanet journal of rare diseases 9, 1-9, 2014 | 67 | 2014 |
| Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs C Schey, PFM Krabbe, MJ Postma, MP Connolly Orphanet journal of rare diseases 12, 1-9, 2017 | 62 | 2017 |
| A review of anemia as a cardiovascular risk factor in patients with myelodysplastic syndromes EN Oliva, C Schey, AS Hutchings American journal of blood research 1 (2), 160, 2011 | 41 | 2011 |
| Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis MP Connolly, E Goodwin, C Schey, J Zummo Pathogens and Global Health 111 (1), 31-44, 2017 | 27 | 2017 |
| Assessing the preferences for criteria in multi-criteria decision analysis in treatments for rare diseases C Schey, MJ Postma, PFM Krabbe, O Topachevskyi, A Volovyk, ... Frontiers in public health 8, 162, 2020 | 14 | 2020 |
| Assessing the relationship between individual attributes identified in review of multi-criteria decision analysis (MCDA) of rare diseases and annual treatment costs in rare … C Schey, J Irwin, M Teneishvili, PFM Krabbe, M Connolly Value in Health 17 (7), A562, 2014 | 8 | 2014 |
| Metastatic renal cell cancer: An analysis of reimbursement decisions C Schey, G Meier, J Pan Advances in Therapy 36, 1266-1278, 2019 | 7 | 2019 |
| The application of multi-criteria decision analysis to inform in resource allocation C Schey, M Postma, P Krabbe, G Medic, M Connolly F1000Research 9, 445, 2020 | 3 | 2020 |
| Multi-criteria decision analysis (MCDA): testing a proposed MCDA model for orphan drugs C Schey, M Connolly Value in Health 17 (7), A556, 2014 | 3 | 2014 |
| Payer Assessment and Reimbursement Policy for Rare Diseases: A Review of the Literature A Hutchings, C Palaska, C Schey, L Pericleous, J Petersen Value in Health 16 (7), A391, 2013 | 1 | 2013 |
| Impact of restricted access to, and low awareness of, mexiletine on people with myotonia: a real-world European survey J Díaz-Manera, JA Urtizberea, C Schey, A Kole, P von Gallwitz, A Whiting, ... Neuromuscular Disorders 33 (2), 208-217, 2023 | | 2023 |
| POSA220 Different Willingness to Pay for Curative Therapies in France: A Cost per Cure Analysis of Medicines in Different Therapeutic Areas A Dinh, C Schey, A Henriksen, S Lopes Value in Health 25 (1), S143-S144, 2022 | | 2022 |
| POSA115 Is There a Difference between the Willingness to Pay for Antimicrobials and Other Curative Treatments? A Cost per Cure Analysis of Curative Therapies in Spain M de Frutos, MÁ Calleja, R Cantón, J Torre-Cisneros, JL Trillo, C Schey, ... Value in Health 25 (1), S56, 2022 | | 2022 |
| IS THERE A DIFFERENCE BETWEEN THE WILLINGNESS TO PAY FOR ANTIMICROBIALS AND OTHER CURATIVE TREATMENTS? A COST PER CURE ANALYSIS OF RECENTLY APPROVED MEDICINES IN THE UK C Schey, W Cowell, M Connolly, S Lopes VALUE IN HEALTH 23, S564-S564, 2020 | | 2020 |
| PMU33 Are There Inequalities in Willingness to Pay for Antimicrobials and Other Curative Treatments in Different Therapeutic Areas? a Cost per Cure Analysis of Recently … C Schey, C Jommi, M Bassetti, M Connolly, A Pitrelli, S Lopes Value in Health 23, S608, 2020 | | 2020 |
| PIN128 Is There a Difference between the Willingness to Pay for Antimicrobials and Other Curative Treatments? a Cost per Cure Analysis of Recently Approved Medicines in the UK C Schey, W Cowell, M Connolly, S Lopes Value in Health 23, S565, 2020 | | 2020 |
| resource allocation [version 1; peer review: 1 approved with C Schey, M Postma, P Krabbe, G Medic, M Connolly | | 2020 |
| Reimbursement decisions on drugs for renal cell carcinoma C Schey PharmacoEconomics & Outcomes News 826, 27-20, 2019 | | 2019 |
| Assessing Multi-Criteria Decision Analysis (MCDA) Attribute Weights Using an Interactive Data Capture Tool C Schey, M Connolly, A Volovyk, O Topachevskyi, N Kotsopoulos Value in Health 21, S220, 2018 | | 2018 |
